Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Aftimos

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Advances in Therapy|October 25, 2011
Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?Philippe Aftimos, Ahmad Awada
Current Treatment Options in Oncology|April 2, 2019
Antibody-Drug Conjugates in Breast Cancer: a Comprehensive ReviewNoam Pondé, Philippe Aftimos, Martine Piccart
Current Opinion in Oncology|February 26, 2015
New generations of targeted therapies fighting the resistance in solid tumorsPhilippe Barthélémy, Philippe Aftimos, Ahmad Awada
Current Opinion in Oncology|July 19, 2016
Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?Gilberto Morgan, Philippe Aftimos, Ahmad Awada
Current Opinion in Oncology|March 14, 2012
Personalized management of patients with solid cancers: moving from patient characteristics to tumor biologyAhmad Awada, Anna M Vandone, Philippe Aftimos
Expert Opinion on Emerging Drugs|January 29, 2016
Emerging drugs targeting human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancerGil Awada, Andrea Gombos, Philippe Aftimos, et al.
Seminars in Cancer Biology|July 29, 2014
Evolving paradigms in multifocal breast cancerRoberto Salgado, Philippe Aftimos, Christos Sotiriou, et al.
Current Opinion in Oncology|April 9, 2014
Impact of tumor sequencing on the use of anticancer drugsFrançois Thomas, Christine Desmedt, Philippe Aftimos, et al.
World Journal of Clinical Oncology|October 26, 2017
Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancerHampig Raphael Kourie, Nicolas Mavroudakis, Philippe Aftimos, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Advances in Therapy|October 25, 2011
Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?Philippe Aftimos, Ahmad Awada
Current Treatment Options in Oncology|April 2, 2019
Antibody-Drug Conjugates in Breast Cancer: a Comprehensive ReviewNoam Pondé, Philippe Aftimos, Martine Piccart
Current Opinion in Oncology|February 26, 2015
New generations of targeted therapies fighting the resistance in solid tumorsPhilippe Barthélémy, Philippe Aftimos, Ahmad Awada
Current Opinion in Oncology|July 19, 2016
Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?Gilberto Morgan, Philippe Aftimos, Ahmad Awada
Current Opinion in Oncology|March 14, 2012
Personalized management of patients with solid cancers: moving from patient characteristics to tumor biologyAhmad Awada, Anna M Vandone, Philippe Aftimos
Expert Opinion on Emerging Drugs|January 29, 2016
Emerging drugs targeting human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancerGil Awada, Andrea Gombos, Philippe Aftimos, et al.
Seminars in Cancer Biology|July 29, 2014
Evolving paradigms in multifocal breast cancerRoberto Salgado, Philippe Aftimos, Christos Sotiriou, et al.
Current Opinion in Oncology|April 9, 2014
Impact of tumor sequencing on the use of anticancer drugsFrançois Thomas, Christine Desmedt, Philippe Aftimos, et al.
World Journal of Clinical Oncology|October 26, 2017
Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancerHampig Raphael Kourie, Nicolas Mavroudakis, Philippe Aftimos, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
Pageof 9